This inventor holds 1 USPTO granted patent. Top assignee: Universita' Degli Studi Di Treiste. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Federico Berti and His Antiviral Patent.
Introduction
Federico Berti is an inventor associated with Trieste, Italy, and the University of Trieste. His patent work concerns peptidomimetic compounds designed to inhibit retroviral proteases, particularly HIV protease.
Latest Patents
Berti is credited with 1 patent: “Peptidomimetic Inhibitors of Retroviral Proteases and Their Use as Antivirals.” The invention describes inhibitors built around a diamino-diol isostere of the dipeptide Phe-Pro, with four stereogenic centers. The compounds were shown to inhibit HIV protease and are proposed for antiviral use, including post-exposure prophylaxis and treatment of retroviral infections. The patent also describes methods for synthesizing the isosteres and inhibitors.
Career Highlights
Berti’s listed organizational affiliation is the University of Trieste, known in Italian as Università degli Studi di Trieste. His patent highlights research into potential antiviral therapies targeting retroviral enzymes.
Collaborations
The patent information names Alessandro Tossi and Pietro Campaner as Berti’s coworkers.
Conclusion
Federico Berti’s recorded invention focuses on peptidomimetic inhibitors of HIV protease and their potential applications in antiviral prevention and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile